Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study (Q80406284)
Jump to navigation
Jump to search
scientific article published on 01 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study |
scientific article published on 01 June 2007 |
Statements
Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study (English)
Lillian L Siu
Denis Soulieres
Eric X Chen
Gregory R Pond
Soo F Chin
Peggy Francis
Luc Harvey
Meri Klein
Wenjiang Zhang
Janet Dancey
Elizabeth A Eisenhauer
Eric Winquist
Princess Margaret Hospital Phase II Consortium
National Cancer Institute of Canada Clinical Trials Group Study